Patents Assigned to The University of North Carolina
-
Patent number: 12270057Abstract: This invention relates to polynucleotides comprising optimized FIG. 4 open reading frame (ORF) sequences, vectors comprising the same, and methods of using the same for delivery of the ORF to a cell or a subject and to treat disorders associated with aberrant expression of a FIG. 4 gene or aberrant activity of a FIG. 4 gene product in the subject, such as CMT4J.Type: GrantFiled: November 5, 2019Date of Patent: April 8, 2025Assignee: The University of North Carolina at Chapel HillInventors: Steven James Gray, Rachel Bailey
-
Patent number: 12264253Abstract: Described herein are non-stoichiometric perovskite ink solutions, comprising: a first composition of formula FA1-xCsxBX3; a second composition of CsX, FAX, REX3, or REX2; and one or more solvents; wherein x, X, RE, and B are as defined herein. Methods for preparing polycrystalline perovskite films using the non-stoichiometric ink solutions and the use of the films in large-size solar modules are additionally described.Type: GrantFiled: August 3, 2021Date of Patent: April 1, 2025Assignee: The University of North Carolina at Chapel HillInventors: Jinsong Huang, Yehao Deng
-
Patent number: 12257321Abstract: This invention relates to polynucleotides encoding mini-dystrophin proteins, viral vectors comprising the same, and methods of using the same for delivery of mini-dystrophin to a cell or a subject.Type: GrantFiled: January 5, 2023Date of Patent: March 25, 2025Assignees: The University of North Carolina at Chapel Hill, Bamboo Therapeutics, Inc.Inventors: Xiao Xiao, Juan Li, Chunping Qiao, Scott W. J. McPhee, Richard J. Samulski, Maritza McIntyre
-
Patent number: 12257314Abstract: The subject matter disclosed herein is directed to nitric oxide releasing particles comprising a mesoporous silica network. Also disclosed are compositions comprising one or more nitric-oxide releasing particles and a polymer. In one aspect, the particles are admixed with the polymer. The compositions exhibit high payloads of nitric oxide release without particle leaching or the need for extremely cold storage conditions.Type: GrantFiled: February 28, 2020Date of Patent: March 25, 2025Assignee: The University of North Carolina at Chapel HillInventors: Mark H. Schoenfisch, Maggie Malone-Povolny
-
Patent number: 12257322Abstract: This invention relates to polynucleotides comprising a nucleotide sequence encoding a PPT1 polypeptide or a fragment thereof, vectors (viral or non-viral vectors) comprising the same, and methods of using the same for delivery of the open reading frame to a cell or a subject and to treat infantile neuronal lipofuscinosis (infantile Batten disease). The polynucleotides comprise an optimized CLN1 open reading frame.Type: GrantFiled: November 2, 2022Date of Patent: March 25, 2025Assignee: The University of North Carolina at Chapel HillInventor: Steven Gray
-
Patent number: 12258545Abstract: A microalgae curtain wall includes photobioreactors, an interior glass panel, an exterior glass panel, and transoms. The photobioreactors are adapted to receive sunlight and carbon dioxide to grow microalgae received therein. The exterior glass panel is offset from the interior glass panel forming a gap therebetween. The transoms hold the interior glass panel and the exterior glass panel therebetween. The transoms suspend the photobioreactors in the gap and between the interior glass panel and the exterior glass panel.Type: GrantFiled: October 14, 2020Date of Patent: March 25, 2025Assignee: The University Of North Carolina At CharlotteInventor: Kyoung Hee Kim
-
Patent number: 12258388Abstract: The present disclosure provides humanized antibodies and antigen-binding fragments thereof that specifically bind to SFRP2 and compositions comprising such humanized antibodies or antigen-binding fragments thereof. In some aspects, the humanized antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased SFRP2, such as cancer. In some aspects, the antibodies or antigen-binding fragments can be used to treat osteosarcoma.Type: GrantFiled: January 12, 2024Date of Patent: March 25, 2025Assignee: The University of North Carolina at Chapel HillInventors: Nancy Demore, Cam Patterson
-
Patent number: 12256588Abstract: The present disclosure is directed to perovskite-based solar cell device structures and compositions comprising one or more near infrared sensitive semiconducting materials. The near infrared sensitive semiconducting materials can extend the photoresponse spectra of the devices to the near infrared region, thereby improving the power conversion efficiency of the solar cell.Type: GrantFiled: April 17, 2020Date of Patent: March 18, 2025Assignee: The University of North Carolina at Chapel HillInventors: Jinsong Huang, Yuze Lin, Shangshang Chen
-
Publication number: 20250066856Abstract: Provided are methods for identifying pancreatic cancer subtypes in a subject and treating the same. In some embodiments, the method comprise obtaining gene expression levels for each of the following genes in the biological sample: GPR87, KRT6A, BCAR3, PTGES, ITGA3, C16orf74, S100A2, KRTS, REG4, ANXA10, GATA6, CLDN18, LGALS4, DDC, SLC40A1, CLRN3; performing pair-wise comparisons of gene expression levels for combinations of these genes; and calculating a Raw Score for the biological sample, wherein the Raw Score is indicative of the pancreatic cancer subtype in the subject. Also provided are methods for identifying differential treatment strategies for subjects diagnosed with PDAC, methods for treating PDAC patients based on the subtype of PDAC the patients have; and methods for classifying subjects diagnosed with PDAC as having a basal-like subtype or a classical subtype of PDAC.Type: ApplicationFiled: April 29, 2024Publication date: February 27, 2025Applicant: The University of North Carolina at Chapel HillInventors: Jen Jen Yeh, Richard Moffitt, Naim Ur Rashid
-
Patent number: 12234377Abstract: Described herein are compositions, devices, and methods for improving a surface property of a substrate. In some embodiments, the hydrophobicity and/or fluorocarbon-phobicity of the surface is increased. Some embodiments include compositions, devices and methods for improving bead loading and/or immiscible oil sealing of microwell array reactions on plastic microfluidic devices.Type: GrantFiled: May 15, 2019Date of Patent: February 25, 2025Assignee: The University of North Carolina at Chapel HillInventors: John Michael Ramsey, William Hampton Henley
-
Patent number: 12209251Abstract: The present invention provides mutant adeno-associated virus serotype 5 (AAV5) that exhibit altered capsid properties, e. g., increased infectivity in human liver cells and/or minimal binding to human neutralizing antibodies. The present invention further provides libraries of mutant AAV5 comprising one or more mutations in a capsid gene. The present invention further provides methods of generating the mutant AAV5 and mutant AAV5 libraries, and compositions comprising the mutant AAV5. The present invention further provides recombinant AAV5 (rAAV5) virions that comprise a mutant capsid protein. The present invention further provides nucleic acids comprising nucleotide sequences that encode mutant capsid proteins.Type: GrantFiled: May 4, 2021Date of Patent: January 28, 2025Assignee: The University of North Carolina at Chapel HillInventors: Xiao Xiao, Randolph Qian, Juan Li
-
Patent number: 12208105Abstract: The present invention relates to methods for attenuating graft-versus-host disease after transplantation of a graft comprising hematopoietic stem cells in a subject. The invention further relates to methods of limiting opportunistic microbial infections in a subject after transplantation of a graft comprising hematopoietic stem cells.Type: GrantFiled: December 3, 2019Date of Patent: January 28, 2025Assignee: The University of North Carolina at Chapel HillInventors: James M. Coghill, Kenneth A. Fowler
-
Patent number: 12209263Abstract: The invention relates to synthetic liver-specific promoters and expression constructs for producing polypeptides and functional nucleic acids in the liver of a subject. The invention further relates to optimized polynucleotide sequences encoding Factor IX proteins, vector comprising the same, and methods of using these compositions to treat a bleeding disorder.Type: GrantFiled: November 17, 2022Date of Patent: January 28, 2025Assignee: The University of North Carolina at Chapel HillInventors: Xiao Xiao, Juan Li
-
Patent number: 12201697Abstract: This invention relates to viral vectors for delivery of alpha-L-iduronidase to the cornea of a subject and methods of using the same for treatment and prevention of corneal clouding and blindness in a subject due to mucopolysaccharidosis I.Type: GrantFiled: August 20, 2021Date of Patent: January 21, 2025Assignee: The University of North Carolina at Chapel HillInventors: Matthew Louis Hirsch, Richard Jude Samulski
-
Patent number: 12199441Abstract: An example apparatus for controlling one or more inverters is provided herein. In some embodiments, the apparatus for controlling one or more inverters may include one or more controllers. In some embodiments, each of the one or more inverters is associated with at least one power source. In some embodiments, each of the one or more controllers may configured to provide droop control, voltage magnitude control, phase control, frequency control and inertia control for an associated inverter of the one or more inverters. In some embodiments, each of the one or more controllers comprises a voltage control loop, a virtual inertia control loop, and a droop control loop enabling the power supplies to sync with a power grid and/or other power supplies when the power supply is disconnected from the power grid and/or other power supplies and/or connected to a power supply to the power grid and/or other power supplies.Type: GrantFiled: February 21, 2023Date of Patent: January 14, 2025Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTEInventors: Madhav Manjrekar, Prithwiraj Roy Chowdhury
-
Patent number: 12195805Abstract: Methods and compositions are provided for determining a subtype of Muscle Invasive Bladder Cancer (MIBC) in an individual by detecting the expression level of at least one classifier biomarker selected from a group of gene signatures for MIBC. Also provided herein are methods and compositions for determining the response of an individual with a MIBC subtype to a therapy such as immunotherapy.Type: GrantFiled: February 13, 2019Date of Patent: January 14, 2025Assignees: GeneCentric Therapeutics, Inc., University of North Carolina at Chapel HillInventors: Hawazin Faruki, Greg Mayhew, Myla Lai-Goldman, Charles Perou
-
Patent number: 12195706Abstract: A method for producing tissue constructs comprising two or more distinct regions, each of which comprises a different cell population or lineage is described. The method involves providing a support substrate or substrate assembly comprising two or more physically distinct regions, wherein the two or more physically distinct regions of the support substrate or substrate assembly are different from each other; and depositing/positioning one or more cells on the support substrate or substrate assembly. The cells can form a continuous monolayer with at least two zones, e.g., a proliferative zone and a nonproliferative zone, that can act as in vitro intestinal models. The models are two-dimensional, thus facilitating rapid and facile imaging. Systems comprising the tissue constructs and methods of using the constructs to study the effects of pharmaceuticals, nutraceuticals, and metabolites on intestinal cells are also described.Type: GrantFiled: September 22, 2023Date of Patent: January 14, 2025Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLInventors: Nancy L. Allbritton, Yuli Wang, Raehyun Kim
-
Patent number: 12195806Abstract: Described herein are assays and methods to detect and/or treat a non-responsive or treatment resistant p16 positive tumor in a subject in need thereof. The disclosed method can also involve determining if the subject is HPV positive or negative, whether the HPV is integrated or episomal, and selecting a suitable treatment based on these determinations. Also disclosed herein is a method of treating an oropharyngeal squamous cell carcinoma in a subject using the arrays and methods disclosed herein.Type: GrantFiled: April 12, 2019Date of Patent: January 14, 2025Assignee: The University of North Carolina at Chapel HillInventors: Wesley Hunter Stepp, Travis Parke Schrank
-
Patent number: 12193852Abstract: Systems and related methods for stationary digital chest tomosynthesis (s-DCT) imaging are disclosed. In some aspects, systems include a stationary x-ray source array with an array of x-ray pixels configured to generate x-ray beams at different viewing angles relative to a subject to be imaged that is stationary, a stationary area x-ray detector configured to record x-ray projection images of the subject, a physiological gating apparatus for monitoring at least one physiological signal of the subject and defining a physiological phase and a time window based on the at least one physiological signal, and a computing platform configured to activate the x-ray pixels based on the physiological phase and the time window and upon receipt of the at least one physiological signal from the physiological gating apparatus in order to synchronize x-ray exposure with the at least one physiological signal of the subject.Type: GrantFiled: April 19, 2021Date of Patent: January 14, 2025Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLInventors: Jianping Lu, Jing Shan, Yueh Lee, Otto Z. Zhou, Jabari Calliste, Christina Inscoe, Pavel Chtcheprov, Andrew Tucker
-
Patent number: 12190436Abstract: Systems and methods for generating multi-view synthetic dental radiographs for intraoral tomosynthesis. In some embodiments, the method includes generating or receiving two-dimensional (2D) projection images, manipulating pixel values contained in each of the plurality of 2D projection images, reconstructing a three-dimensional (3D) image space from information available in the plurality of 2D projection images, the 3D image space comprising voxel values, manipulating the voxel values in the 3D image space using one or more tunable weighting algorithms that can be adjusted to emphasize one or more features of interest of each image in the 3D image space, generating a plurality of synthetic dental radiographs from multiple views using information available in the 3D image space, and displaying one or more of the synthetic dental radiographs. In some embodiments, the system includes a display in communication with an image processing system comprising one or more processors for performing the method.Type: GrantFiled: November 18, 2021Date of Patent: January 7, 2025Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLInventors: Connor Puett, Otto Z. Zhou, Jianping Lu, Christina Inscoe